|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. |
| 公司地址
| 960 San Antonio Road, Palo Alto, CA, USA, 94303 |
| 電話號碼
| +1 650 516-4310 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.scilexholding.com |
| 員工數量
| 34 |
| Dr. Henry Ji,PhD |
Executive Chairperson of the Board, Chief Executive Officer and President |
美元 1.25M |
10/04/2026 |
| Mr. Hoi Stephen Ma |
Chief Operating Officer, Director, Chief Financial Officer, Senior Vice President, Secretary and Principal Accounting Officer |
美元 600.00K |
10/04/2026 |
|
|
| Dr. Jay Chun, M.D.,PhD |
Independent Director |
10/04/2026 |
| Dr. Yue Alexander Wu, PhD |
Independent Director |
10/04/2026 |
| Mr. Dorman Followwill |
Independent Director |
10/04/2026 |
| Dr. Henry Ji,PhD |
Executive Chairperson of the Board, Chief Executive Officer and President |
10/04/2026 |
| Mr. Hoi Stephen Ma |
Chief Operating Officer, Director, Chief Financial Officer, Senior Vice President, Secretary and Principal Accounting Officer |
10/04/2026 |
|
|
|
|
